2004-001589-42: Transdermal lisuride:Phase II/III study (efficacy and tolerance) of transdermal lisuride (patches) in patients with Restless Legs Syndrome (RLS) |
|
|
| Ongoing | 3 | 200 | Europe | Lisuride TTS, NBt P 102 DZ, Transdermal patch, Dopergin | NeuroBiotec GmbH | Patients suffering from Restless Legs Syndrome (RLS) | | | | |
2006-003732-30: Transdermal Use of Lisuride in Early Parkinson´s Disease: A double blind, randomized, Placebo and Pramipexole controlled study to evaluate the efficacy and safety of Lisuride TTS |
|
|
| | 3 | 140 | Europe | Lisuride TTS 10cm², Lisuride TTS 20cm², Sifrol 0,088, Sifrol 0,18, Sifrol 0,35, Sifrol 0,7, Sifrol 0,088, Sifrol 0,18, Sifrol 0,35, Sifrol 0,7 | Axxonis Pharma AG, NeuroBiotec Pharma AG, NEUROBIOTEC GMBH | Early Parkinson\'s Disease | | 12/09 | | |
